Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02907450
Other study ID # BRD/11/2-W
Secondary ID 2011-A01106-35
Status Completed
Phase N/A
First received September 9, 2016
Last updated September 14, 2016
Start date October 2012
Est. completion date March 2015

Study information

Verified date September 2016
Source Nantes University Hospital
Contact n/a
Is FDA regulated No
Health authority France : Agence Nationale de Sécurité du Médicament et des produits de santé (ANSM)
Study type Interventional

Clinical Trial Summary

The TwiCare® device is a removable brace that can be used in orthopedic referred to stimulate mandibular growth or in interception / contention.

The proposed research project will focus initially on assessing the comfort and safety of TwiCare® device. The orthopedic efficiency therefore not part of this study.

The comfort and safety of the brace will be evaluated firstly by the practitioner during the visit control around 2 ½ months (or 11 weeks) after the start of the port of the device, and with the help of a questionnaire completed by the patient at home 3 weeks and 6 weeks after the start of the port of the device, and during the control visit at 11 weeks.


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date March 2015
Est. primary completion date March 2015
Accepts healthy volunteers No
Gender Both
Age group 8 Years to 18 Years
Eligibility Inclusion Criteria:

- male or female patients, where the laying of a brace phase of interception or contention after dental-facial orthodontic treatment is indicated (an intended age range of 8-18 years, not exhaustive or limiting) , recipient of a social security scheme, for which a management of the orthosis is acquired.

- incisor width compatible with the sizes of TwiCare® orthotics available, according to manufacturer's recommendations

- patient in good general health

- parent or guardian able to receive clear information, and express their opposition not to the patient's participation in this research

- for patients with malocclusions, the incisors (maxillary and mandibular) should be aligned.

Exclusion Criteria:

- General chronic health problem, unbalanced

- obvious oral ventilation

- history of temporomandibular dysfunction

- nocturnal episodes of severe bruxism

- unbalanced periodontal disease

- allergies or intolerances known to one of the constituents of the orthosis

- opposition of representatives of the parental authority (parent or guardian) or the patient himself at the patient's participation in this research

- patient unable to respond to the questionnaire

- monitoring difficulties (going on holiday, imminent change, remoteness, lack of motivation)

- simultaneous participation in intervention research

- pregnant Patient on examination of the latter, according to his age

- Incisive (maxilla and / or mandible) unaligned

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Intervention

Device:
TwiCare®.


Locations

Country Name City State
France CHU de Nantes -Service d'Odontologie Restauratrice et Chirurgicale Nantes

Sponsors (1)

Lead Sponsor Collaborator
Nantes University Hospital

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary No appearance of more than one injury that can not be attributed to causes other than the orthosis 11 weeks Yes
Secondary The clinical evaluation of the compliance of the orthosis (occurrence of tooth movement, state of the brace, usual patient interview) 11 weeks No
Secondary The subjective assessment of the compliance of wearing the brace by patient by self questionnaire 11 weeks No
Secondary The subjective assessment of patient acceptability questionnaires self treatment 11 weeks No
Secondary The support type envisaged endline by the doctor 11 weeks No